GLP-1 Weight Management
A supported path to a healthier weight
Personalized medical care. Practical habits. Progress that starts with you.
MEDICAL WEIGHT MANAGEMENT • TAHLEQUAH, OK
Your goals deserve a plan—and a partner
Weight management can be challenging. You deserve care that listens, considers your health, and helps you choose a practical next step.
At 401 Medical Center, explore whether GLP-1-based medication fits your weight management plan. Start with a clinical evaluation, talk through the options, and make an informed choice with your provider.
Medication can support weight loss when paired with nutrition, physical activity, and ongoing care. Results vary; there is no guaranteed amount or timeline.

Support for appetite regulation
GLP-1-based medicines act on hormone receptors involved in appetite, food intake, and blood sugar regulation. They can help people feel fuller and eat less. Semaglutide targets the GLP-1 receptor; tirzepatide targets both GIP and GLP-1 receptors.
These are prescription medications. Choosing a treatment involves more than comparing the number of receptors it targets—your health history, response, side effects, and the exact product all matter.
Medication options & current clinic pricing
GLP-1 RECEPTOR AGONIST
Semaglutide
$350 per bottle
In-office option: $60
Per weekly injection, when prescribed.
One receptor pathway: GLP-1. This pathway influences appetite and blood sugar regulation; it is not limited to the gut. Discuss the exact formulation with your provider.
DUAL GIP / GLP-1 RECEPTOR AGONIST
Tirzepatide
$450 per bottle
In-office option: $70
Per weekly injection, when prescribed.
Two receptor pathways: GIP and GLP-1. These are hormone receptor targets, not separate “gut” and “brain” pathways. Your provider helps assess suitability and explains the prescribed product.
Bottle prices are not monthly prices. Bottle volume, concentration, and prescribed dose determine how long a bottle lasts. Confirm the exact product, pharmacy, included services, and any consultation or testing charges before treatment. Prescription and eligibility are required.
What about retatrutide?
Retatrutide is an investigational medicine targeting GIP, GLP-1, and glucagon receptors. It is not FDA approved, and FDA states that it cannot be used in compounding. It is not presented here as an available routine treatment or priced service.
Learn more: Lilly’s retatrutide information and FDA safety information.
A clear path from questions to care
01 • START WITH YOU
Review your health
Discuss your weight history, goals, current medicines, and medical conditions. Your clinician assesses eligibility and any necessary tests.
02 • MAKE A PLAN
Choose thoughtfully
Review benefits, risks, costs, and alternatives. If medication is prescribed, receive clear instructions for your exact product and dose.
03 • KEEP CHECKING IN
Build sustainable habits
Track progress and tolerance with your provider while supporting nutrition, hydration, activity, and long-term weight management.
Frequently asked questions
Could I be a candidate?
Many adult weight management medicines are used for obesity, or overweight with a weight-related medical condition. Eligibility depends on the product and your complete clinical assessment. A visit does not guarantee a prescription.
What is the difference between approved and compounded products?
FDA approval applies to a specific drug product and indication, not every product containing the same ingredient. Compounded semaglutide and tirzepatide are not FDA approved and are not reviewed by FDA for safety, effectiveness, or quality before marketing. FDA advises that compounded medicines be used only when a patient’s medical needs cannot be met by an approved drug. Ask which product you are being prescribed and why.
How are doses selected?
Your prescriber sets the dose and any gradual increases based on the product and your response. Do not increase it on your own. If using a vial, ask the clinician or pharmacist to demonstrate the exact volume and syringe markings; concentrations can differ.
What side effects and risks should I know?
Common effects include nausea, vomiting, diarrhea, constipation, and abdominal discomfort. Serious risks can include pancreatitis, gallbladder problems, dehydration-related kidney injury, severe stomach problems, and allergic reactions. Low blood sugar risk can increase with insulin or certain diabetes medicines. Review the full Medication Guide for your prescribed product.
Who should avoid these medications?
Semaglutide and tirzepatide carry boxed warnings about thyroid C-cell tumors seen in rodents; the human risk is unknown. Do not use them with a personal or family history of medullary thyroid carcinoma or MEN 2, or a serious allergy to the product. Weight-loss treatment is not appropriate during pregnancy. Tell your provider about pregnancy plans, breastfeeding, digestive problems, and all medications.
What else should I tell my provider?
Discuss planned anesthesia or sedation and any other GLP-1-based medicine. Tirzepatide can reduce the effectiveness of oral hormonal birth control; its labeling advises a nonoral method or added barrier contraception for 4 weeks after starting and after each dose increase.
Will I need long-term care?
Weight management is an ongoing process. Your provider reviews benefits and risks over time, including what may happen if medication is stopped and how to support weight maintenance.
Is financing available?
Ask our team about service eligibility and costs, or explore Cherry financing. Financing is subject to approval; plans and terms vary.
Take the first step—with support
Let’s talk about your goals and whether medical weight management is right for you.
Book a Weight Management Visit
Call (918) 316-4473
401 E Downing St • Tahlequah, OK
Individual results vary. Educational information does not replace medical advice or product labeling. Sources: NIDDK weight management medications, FDA compounded GLP-1 information, semaglutide labeling, and tirzepatide labeling.
Contact Us
Ask a question or book an appointment below.
For emergencies call 911 or visit your nearest hospital.